Primary tabs
Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.
Dosing: Adult Antimicrobial Dosing, Non-dialysis
| Indication | Dose | Notes |
|---|---|---|
| Pneumocystis PROPHYLAXIS | 1500 mg PO Q24H with food | For patients who are intolerant of sulfa |
| Pneumocystis TREATMENT (mild diease) | 750 mg PO Q12H with food |
For patients who are intolerant of sulfa Mild disease (A-a O2 gradient < 35 mmHg and PAO2 >70 mmHg) |
Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis
| Indication | Dose | Notes |
|---|---|---|
| Pneumocystis PROPHYLAXIS | 1500 mg PO Q24H with food | For patients who are intolerant of sulfa |
| Pneumocystis TREATMENT (mild disease) | 750 mg PO Q12H with food |
For patients who are intolerant of sulfa Mild disease (A-a O2 gradient < 35 mmHg and PAO2 >70 mmHg) |
Dialysis Notes
Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. For detailed view of dialysis dosing and evidence, see Dosing in Hemodialysis document.